학술논문
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)
Document Type
Article
Author
Source
In: European Journal of Cancer . (European Journal of Cancer, April 2024, 201)
Subject
Language
English
ISSN
18790852
09598049
09598049